デフォルト表紙
市場調査レポート
商品コード
1701725

感染管理市場の市場規模、シェア、成長分析、製品別、用途別、流通チャネル別、エンドユーザー別、地域別 - 産業予測 2025~2032年

Infection Control Market Size, Share, and Growth Analysis, By Product, By Application, By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 165 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
感染管理市場の市場規模、シェア、成長分析、製品別、用途別、流通チャネル別、エンドユーザー別、地域別 - 産業予測 2025~2032年
出版日: 2025年04月05日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

感染管理市場規模は2023年に492億米ドルと評価され、2024年の525億9,000万米ドルから2032年には896億9,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは6.9%で成長する見通しです。

感染管理市場は、臨床転帰を成功させるために感染管理を重視する外科手術や治療手技の増加によって大きな成長を遂げています。COVID-19の大流行により、ヘルスケア施設、製薬会社、医療機器メーカー全体で滅菌・消毒の需要が高まっており、米国の除菌剤生産量は60%増加しています。滅菌方法の技術的進歩や滅菌サービスのアウトソーシング傾向の高まりがさらに市場拡大に寄与しています。さらに、感染予防対策の強化を推進することを目的とした政府の取り組みや、世界保健機関(WHO)のような組織による世界のガイドラインも、意識を高め予防行動を強化しています。こうした機運の高まりにより、感染管理市場は今後数年間で力強い成長を遂げるものと思われます。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術分析
  • 規制分析

感染管理市場規模:製品別& CAGR(2025-2032)

  • 市場概要
  • 滅菌製品
    • 加熱滅菌装置
    • 湿熱滅菌装置
    • 乾熱滅菌装置
    • 低温殺菌装置
    • 放射線滅菌装置
  • 清掃・消毒製品
    • 消毒器
    • 洗濯機消毒器
    • フラッシャー消毒器
    • その他
    • 内視鏡再処理装置システム
    • ハイエンド内視鏡再処理装置システム
    • 中規模内視鏡再処理装置システム
    • ローエンド内視鏡再処理装置システム
  • 個人用防護バリア
  • 内視鏡再処理製品
  • 抗菌表面
  • その他の感染管理製品

感染管理市場規模:用途別& CAGR(2025-2032)

  • 市場概要
  • 手術器具
  • 内視鏡
  • 超音波プローブ
  • その他

感染管理市場規模:流通チャネル別& CAGR(2025-2032)

  • 市場概要
  • 直接入札
  • 小売売上高
  • サードパーティディストリビューター

感染管理市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 病院
  • クリニック
  • 医療機器企業
  • 製薬およびバイオテクノロジー企業
  • 研究所
  • その他

感染管理市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024年)

主要企業プロファイル

  • 3M Company(USA)
  • Ecolab Inc.(USA)
  • Getinge AB(Sweden)
  • STERIS plc(Ireland)
  • Fortive Corporation(USA)
  • Cardinal Health, Inc.(USA)
  • Medline Industries, LP(USA)
  • Paul Hartmann AG(Germany)
  • Becton, Dickinson and Company(BD)(USA)
  • Johnson & Johnson(USA)
  • MMM Group(Germany)
  • Belimed AG(Switzerland)
  • Envista Holdings Corporation(USA)
  • SC Johnson Professional(USA)
  • Reckitt Benckiser Group plc(UK)
  • Gojo Industries, Inc.(USA)
  • Diversey Holdings, Ltd.(USA)

結論と提言

目次
Product Code: SQMIG35A2623

Infection Control Market size was valued at USD 49.2 billion in 2023 and is poised to grow from USD 52.59 billion in 2024 to USD 89.69 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The infection control market is experiencing significant growth driven by an increase in surgical and therapeutic procedures emphasizing infection management for successful clinical outcomes. The COVID-19 pandemic has heightened the demand for sterilization and disinfection across healthcare facilities, pharmaceutical companies, and medical device manufacturers, with sanitizer production in the U.S. rising by 60%. Technological advancements in sterilization methods and the growing trend of outsourcing sterilization services further contribute to market expansion. Additionally, government initiatives aimed at promoting heightened infection prevention measures and global guidelines from organizations like the World Health Organization are also fostering awareness and enhancing preventive actions. This collective momentum positions the infection control market for robust growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Infection Control market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Infection Control Market Segments Analysis

Global Infection Control Market is segmented by Product, Application, Distribution Channel, End User and region. Based on Product, the market is segmented into Sterilization Products, Cleaning and Disinfection Products, Personal Protective Barriers, Endoscope Reprocessing Products, Anti-Microbial Surfaces and Other Infection Control Products. Based on Application, the market is segmented into Surgical Instruments, Endoscopes, Ultrasound Probes and Others. Based on Distribution Channel, the market is segmented into Direct Tender, Retail Sales and Third Party Distributors. Based on End User, the market is segmented into Hospitals, Clinics, Medical Device Companies,Pharmaceuticaland Biotechnology Companies, Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Infection Control Market

The Infection Control market is significantly driven by the escalating prevalence of healthcare-associated infections. This rise has heightened awareness among healthcare providers regarding the critical importance of effective infection prevention strategies, as these infections affect millions of patients annually. Consequently, there has been a surge in expenditure related to infection control practices and consumables, including personal protective equipment (PPE), disinfectants, and sterilization tools. Healthcare organizations are now adopting a comprehensive approach to infection control, prioritizing patient safety and the quality of care. As a result, there is an increasing demand for innovative solutions designed to minimize infection risks and enhance overall healthcare delivery.

Restraints in the Infection Control Market

One significant restraint in the infection control market is the high cost associated with advanced technologies. Implementing effective infection control strategies often necessitates substantial investments in sophisticated equipment, ongoing maintenance, and staff training. Smaller healthcare facilities may struggle to afford these essential solutions, which can hinder their ability to adhere to proper infection control protocols. Consequently, the financial burden posed by these expenditures can stifle market expansion and limit the adoption of innovative products and technologies. As many companies grapple with the challenge of delivering cost-effective infection control measures that meet stringent quality standards, this situation poses barriers to overall market growth.

Market Trends of the Infection Control Market

The Infection Control market is witnessing a significant trend towards high-tech advancements, driven by the increasing adoption of automation and digitalization in healthcare settings. Healthcare institutions are leveraging smart technologies, including automatic disinfection systems and real-time monitoring solutions, to enhance their infection prevention measures. These innovations streamline processes and provide crucial insights for compliance tracking and identifying improvement areas. As technology becomes embedded in infection control strategies, it is anticipated that patient safety and operational efficiency will experience a transformative boost, reshaping the landscape of infection management and positioning technology at the forefront of infection control initiatives.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Regulatory Analysis

Global Infection Control Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Sterilization Products
    • Heat Sterilization Equipment
    • Moist Heat Sterilization Equipment
    • Dry Heat Sterilization Equipment
    • Low-Temperature Sterilization Equipment
    • Radiation Sterilization Equipment
  • Cleaning and Disinfection Products
    • Disinfector
    • Washer Disinfector
    • Flusher Disinfector
    • Others
    • Endoscopic Reprocessor Systems
    • High-End Endoscopic Reprocessor Systems
    • Mid-Range Endoscopic Reprocessor Systems
    • Low-End Endoscopic Reprocessor Systems
  • Personal Protective Barriers
  • Endoscope Reprocessing Products
  • Anti-Microbial Surfaces
  • Other Infection Control Products

Global Infection Control Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Surgical Instruments
  • Endoscopes
  • Ultrasound Probes
  • Others

Global Infection Control Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Direct Tender
  • Retail Sales
  • Third Party Distributors

Global Infection Control Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Clinics
  • Medical Device Companies
  • Pharmaceutical and Biotechnology Companies
  • Laboratories
  • Others

Global Infection Control Market Size & CAGR (2025-2032)

  • North America (Product, Application, Distribution Channel, End User)
    • US
    • Canada
  • Europe (Product, Application, Distribution Channel, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Application, Distribution Channel, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Application, Distribution Channel, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, Distribution Channel, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • 3M Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ecolab Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • STERIS plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fortive Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medline Industries, LP (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Paul Hartmann AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MMM Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Belimed AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Envista Holdings Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SC Johnson Professional (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reckitt Benckiser Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gojo Industries, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diversey Holdings, Ltd. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations